Meloxicam is developed for the treatment of rheumatoid arthritis and osteoarthritis. It is currently for the treatment of osteoarthritis and rheumatoid arthritis.
C Hawkey,; A Kahan,; K Steinbrück,; C Alegre,; E Baumelou,; B Bégaud,; J Dequeker,; H Isomäki,; G Littlejohn,; J Mau and S Papazoglou.Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.. Rheumatology. 1998, 37(9), 937-945.
D. Türck,; W. Roth,; U. Busch. A Review of the Clinical Pharmacokinetics of Meloxicam. Rheumatology. 1996, 3513-16.
Mentions de danger (UE): H302-H315-H319-H335
Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Mentions de prudence: P261-P280a-P305+P351+P338-P304+P340-P405-P501a
Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves and eye/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.